Formulation for gonadotropins
AssigneeCadila Healthcare Limited
InventorsChintan PATEL, Mukesh MAHAJAN, Sanjay BANDYOPADHYAY, Sanjee Kumar MENDIRATTA, Bhatt CHANDRESH
Life of this patent
Estimating the term…
Loading patent…
AssigneeCadila Healthcare Limited
InventorsChintan PATEL, Mukesh MAHAJAN, Sanjay BANDYOPADHYAY, Sanjee Kumar MENDIRATTA, Bhatt CHANDRESH
Estimating the term…
The present invention relates to a stable composition for gonadotropins. It provides a composition useful for stabilization of gonadotropins while preventing aggregation, dissociation, fragmentation and formation of oxidized species variants in solution for injection. Thus, it prevents instability of protein or polypeptide molecules caused due to aggregation or fragmentation or oxidation during or after formulation. Also, it provides a pharmaceutical composition of gonadotropins, which can be therapeutically used for the treatment of various indications either in single-dose form or in multi-dose form.
1-28. (canceled)
A liquid pharmaceutical formulation comprising an effective amount of gonadotropin in a buffer system, polyethylene glycol as a stabilizer, suitable preservative and optionally other suitable excipients.
Dependencies are inferred from the claim text.